Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

While Washington Stews, You Can Cash In on the Biggest "Tax-Inversion" Deal in History

Back in June 2012, we recommended that you pick up shares of Big Pharma player Abbott Laboratories Inc. (NYSE: ABT). The reason: Abbott was planning to split in two at the end of the year, meaning folks who took our advice would end up with stakes in two companies for the price of one.

There was more than bargain-basement thinking at work here.

You see, these corporate breakups – known as spin-offs – have a habit of turning into market-beating profit plays. And the newly minted spin-off firms often end up as takeover fodder – also at big profits.

Abbott followed part of that blueprint.

  • Featured Story

    Buy, Sell or Hold: Oracle Corp. (NASDAQ: ORCL) is The Last Cash Cow

    Today marks my 117th and final article at Money Morning.

    Viewed as a portfolio, I'm proud that those 117 calls are up on average. Before we get into my take on Oracle Corp (NASDAQ: ORCL) I'd like to take a look back over years.

    The 2010 picks have held up nicely with 12 positive and just six negative, for a 10 percent positive return on average, as of this writing.

    The hot long ideas of 2011 turned out to be El Paso (NYSE: EP) and Sturm, Ruger & Co. (NYSE: RGR). El Paso is up 48% while Ruger is up 78%.

    So far in 2012 the column's best sell idea, Petrobras (NYSE ADR: PBR), has dropped 15% since January 24. Our Jan. 30 "Buy" recommendation on Apple (NASDAQ: AAPL) is up 32%.

    It's been a great run and my thanks again to the entire Money Morning staff for the opportunity.

    Now, let's talk about the one company that Buy, Sell or Hold has not covered yet but I believe is deserving of the column's final recommendation: Oracle Corp (NASDAQ: ORCL).

    To continue reading, please click here...

    Read More...
  • orcl message